RCSB PDB - LYS Ligand Summary Page

Chemical Component Summary
Name	LYSINE
Identifiers	[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium
Formula	C₆ H₁₅ N₂ O₂
Molecular Weight	147.19
Type	L-PEPTIDE LINKING
Isomeric SMILES	C(CC[NH3+])C[C@@H](C(=O)O)N
InChI	InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1
InChIKey	KDXKERNSBIXSRK-YFKPBYRVSA-O

Chemical Details
Formal Charge	1
Atom Count	25
Chiral Atom Count	1
Bond Count	24
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00123
Name	L-Lysine
Groups	approved nutraceutical
Description	L-Lysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG. L-Lysine is a base, as are arginine and histidine. The ε-amino group acts as a site for hydrogen binding and a general base in catalysis. Common posttranslational modifications include methylation of the ε-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell.
Synonyms	L-Lysin Lysine acid L-Lysine hydrochloride Lysine (S)-lysine L-Lysine monohydrate Lysina (S)-2,6-diaminohexanoic acid L-lys L-2,6-Diaminocaproic acid (S)-α,ε-diaminocaproic acid 6-ammonio-L-norleucine L-Lysine acetate Lysinum L-Lysine LYS
Brand Names	Smofkabiven Extra Nitrogen Electrolyte Free Periolimel 2.5% E Olimel 7.6% E Travasol Inj Without Electrolytes 8.5% Premasol - sulfite-free (Amino Acid) 4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose 4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Clinimix E Travasol Amino Acid Inj 5.5% 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Aminosyn Sulfite Free Travasol 4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix Clinisol Aminosyn II with Electrolytes Aminosyn II 7% With 10% Dextrose Smofkabiven Electrolyte Free 8.5% Freamine III Aminosyn II with Electrolytes in Dextrose with Calcium 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix NephrAmine 4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix Olimel 7.6% Primene Aminosyn II 7% M In 10% Dextrose(dual Chamber) Aminosyn II 8.5% M In 20% Dextrose (dual Chamber) Aminosyn RF 4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Vamin N Primene 10%-liq IV Aminosyn-PF 7% Travasol Amino Acid Inj 8.5% 4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix 2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix Aminosyn RF Injection Kabiven Nutrineal Pd4 Olimel 5.7% E Aminosyn-PF 10% FreAmine III Synthamin Travasol E Olimel 3.3% E Aminosyn II 7% Injection TrophAmine Novamine Plenamine Aminosyn 2.75% Travas. Amino Acid InJ.W.elecw.25%dex Aminosyn II In Dextrose Injection Aminosyn-PF Aminosyn 8.5% 5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose HepatAmine 20% Prosol ProSol 5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose Effervescent Potassium Chloride Smofkabiven Extra Nitrogen 4.25%travasol Amino Acid InJ.W.elecw.5%dex. Aminosyn 3.5% M Renamin (amino Acids) Injection Aminosyn II in Dextrose Aminosyn II 10% With Electrolytes Clinimix Aminosyn II Vamin 18 Electrolyte-free 2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix Hepatasol Aminosyn II 8.5% With 50% Dextrose 2.75%travasol Amino Acid InJ.W.eleC.W.5%dex. 5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Olimel 4.4% RenAmin Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec 4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Aminosyn 5% ProcalAmine Aminosyn II and Dextrose Travasol Inj Without Electrolytes 5.5% Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Olimel 5.7% Olimel 4.4% E 4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose 2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix 4.25%trav. Amino Acid InJ.W.O.elect.5%dext. Smofkabiven Aminosyn 10% W Electrolytes FreAmine HBC Aminosyn HF Aminosyn II 8.5% Injection Aminosyn 8.5% Injection With Electrolytes Aminosyn 7% Xyzmune Primene 10% 2.5%travasol Amino Acid InJ.W.eleC.W.25%dex Aminosyn II 7% With 50% Dextrose Smofkabiven Peripheral Nephramine Liq IV Aminosyn II 5% Inj Perikabiven
Indication	Supplemental L-lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
Categories	Amino Acids Amino Acids, Basic Amino Acids, Diamino Amino Acids, Essential Amino Acids, Peptides, and Proteins Blood and Blood Forming Organs Blood Substitutes and Perfusion Solutions Detoxifying Agents for Antineoplastic Treatment Dietary Supplements I.V. Solution Additives Lysine Supplements
ATC-Code	V03AF11 B05XB03
CAS number	56-87-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
High affinity cationic amino acid transporter 1	MGCKVLLNIGQQMLRRKVVDCSREETRLSRCLNTFDLVALGVGSTLGAGV...	unknown
Cationic amino acid transporter 4	MARGLPTIASLARLCQKLNRLKPLEDSTMETSLRRCLSTLDLTLLGVGGM...	unknown
Cationic amino acid transporter 3	MPWQAFRRFGQKLVRRRTLESGMAETRLARCLSTLDLVALGVGSTLGAGV...	unknown
Low affinity cationic amino acid transporter 2	MIPCRAALTFARCLIRRKIVTLDSLEDTKLCRCLSTMDLIALGVGSTLGA...	unknown
Lysine--tRNA ligase	MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQ...	unknown
Monocarboxylate transporter 10	MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVEL...	unknown	substrate,inhibitor
Solute carrier family 22 member 4	MRDYDEVIAFLGEWGPFQRLIFFLLSASIIPNGFNGMSVVFLAGTPEHRC...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Resource Name	Reference
CCDC/CSD	LYSASP
PubChem	641599
PubChem	24848423
PubChem	5460926
ChEBI	CHEBI:32551

180685 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

LYS

LYSINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References

Prepare Data

Validate Data

Deposit Data

Deposition Help & Resources

180685 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

LYS

LYSINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References